bradykinin, (thi-ala)(5,8)-phe(7)- has been researched along with histamine in 1 studies
| Studies (bradykinin, (thi-ala)(5,8)-phe(7)-) | Trials (bradykinin, (thi-ala)(5,8)-phe(7)-) | Recent Studies (post-2010) (bradykinin, (thi-ala)(5,8)-phe(7)-) | Studies (histamine) | Trials (histamine) | Recent Studies (post-2010) (histamine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 37,718 | 1,372 | 3,457 |
| Protein | Taxonomy | bradykinin, (thi-ala)(5,8)-phe(7)- (IC50) | histamine (IC50) |
|---|---|---|---|
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | 0.1585 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.1585 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, MF; Ouyang, CH; Teng, CM; Wang, JP | 1 |
1 other study(ies) available for bradykinin, (thi-ala)(5,8)-phe(7)- and histamine
| Article | Year |
|---|---|
Edematous response caused by [Thi5,8,D-Phe7]bradykinin, a B2 receptor antagonist, is due to mast cell degranulation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Cytoplasmic Granules; Dose-Response Relationship, Drug; Edema; Glucuronidase; Histamine; Mast Cells; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1989 |